Related Experiment Video
Updated: Dec 3, 2025

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Parachute tricuspid valve: a systematic review
1Department of Cardiothoracic Surgery, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, 389 Longdejing Street, Chengxiang District, Putian, 351100, Fujian Province, China. shiminyuan@126.com.
A parachute tricuspid valve is a rare congenital heart defect. This review details its morphology, diagnosis, and treatment, noting that while some patients need intervention for severe symptoms, others remain asymptomatic.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Cardiac Surgery
Background:
- Parachute tricuspid valve is an exceedingly rare congenital cardiac anomaly.
- Its morphological characteristics and clinical significance remain incompletely understood.
- This systematic review aims to elucidate these aspects.
Purpose of the Study:
- To comprehensively review the literature on parachute tricuspid valve.
- To describe its morphological and clinical features.
- To discuss diagnostic modalities, treatment strategies, and patient outcomes.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Literature search across PubMed, Highwire Press, and Cochrane Library databases.
- Inclusion of 13 reports comprising 14 patients diagnosed between 1979 and 2019.
Main Results:
- A single papillary muscle in the right ventricle was a consistent finding.
- Tricuspid valve dysfunction varied, including regurgitation (60%), stenosis (30%), and normal function (10%).
- 40% of patients were asymptomatic or mildly symptomatic; 60% required surgical/interventional treatment for severe symptoms or associated defects.
Conclusions:
- Parachute tricuspid valve management depends on symptom severity and associated cardiac anomalies.
- Surgical or interventional treatment is indicated for severe symptoms, right ventricular inflow obstruction, or tricuspid stenosis.
- Patient outcomes are variable, with a reported survival rate of 70%.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Aortic Regurgitation I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

